Table 4:
Results of PRS derived using COGA SRE GWAS summary statistics. P<0.0125 are in bold.
| AD | DSM-IV AD criterion count | ||||
|---|---|---|---|---|---|
| Discovery dataset | Test dataset | R2 | p value | R2 | p value |
| SRE-T COGA-EA | SAGE-EA | 2.48% | 4.13E-07 | 1.37% | 8.55E-07 |
| SRE-T COGA-EA | OZALC-EA | 0.34% | 0.05 | 0.60% | 1.14E-03 |
| SRE-T COGA-AA | SAGE-AA | 1.49% | 6.10E-03 | 1.04% | 1.72E-03 |
| SRE-T COGA-AA | Yale-Penn-AA | 0.36% | 0.03 | 0.05% | 0.33 |
| SRE-5 COGA-EA | SAGE-EA | 0.88% | 2.37E-03 | 0.61% | 1.08E-03 |
| SRE-5 COGA-EA | OZALC-EA | 0.14% | 0.21 | 0.47% | 3.85E-03 |
| SRE-5 COGA-AA | SAGE-AA | 0.53% | 0.10 | 0.34% | 0.07 |
| SRE-5 COGA-AA | Yale-Penn-AA | 0.0007% | 0.92 | 0.03% | 0.43 |